Demographics and RIT Outcome
| Patient code | Age (y) | Sex | Histopathology | Location | CEA (ng/mL) | Prior treatments | BsmAb (mg/m2) | Hapten (GBq/m2) | Morphologic response | Biomarker response |
|---|---|---|---|---|---|---|---|---|---|---|
| 01-16 | 49 | M | Rectum adenocarcinoma | Pelvis | 71 | Su, C, R | 75 | 1.8 | Progression | Progression |
| 01-17 | 51 | F | Rectum adenocarcinoma | Lung | 50 | Su, C | 75 | 1.8 | St (3 mo) | St (3 mo) |
| 01-18 | 59 | M | Colon adenocarcinoma | Lung | 499 | Su, C | 75 | 1.8 | Progression | Progression |
| 01-19 | 47 | M | MTC | Liver, bone | 258 | Su | 75 | 1.8 | St (12 mo+) | ND* |
| 01-20 | 36 | M | MTC | Lung, bone | 6 | Su | 75 | 1.8 | St (12 mo+) | St (12 mo+) |
| 01-21 | 58 | M | MTC | Lung, chest, bone | 156 | Su, R | 75 | 1.8 | St (6 mo) | St (6 mo) |
| 01-23 | 56 | M | MTC | Neck, bone, lung, chest, liver | 114 | Su, R | 75 | 1.8 | St (3 mo) | St (3 mo) |
| 01-24 | 34 | F | Colon adenocarcinoma | Lung, liver, pelvis | 226 | Su, C | 40 | 1.1† | Progression | Progression |
| 03-25 | 57 | M | SCLC | Lung, liver | 229 | ND | 75 | 2.3 | St (3 mo) | St (3 mo) |
| 01-26 | 38 | F | MTC | Neck, chest, lung, liver, kidney, bone | 322 | Su, C | 75 | 1.8 | Progression | Progression |
| 01-27 | 44 | F | MTC | Abdomen | 78 | Su | 75 | 1.8 | St (12 mo+) | ND* |
| 01-28 | 56 | H | Rectum adenocarcinoma | Chest, lung, pelvis | 458 | Su, C, R | 40 | 2.3 | Progression | Progression |
| 02-29 | 55 | M | Lung adenocarcinoma | Lung | 20 | Su, C | 75 | 1.8 | Progression | Progression |
| 01-30 | 69 | M | SCLC | Lung, chest | 10 | C, R | 40 | 2.3 | Progression | Progression |
| 03-31 | 66 | M | SCLC | Lung, liver | 14 | C, R | 40 | 2.3 | Progression | Progression |
| 02-32 | 53 | F | Pleura adenocarcinoma | Lung | 14 | C | 40 | 2.3 | Progression | Progression |
| 01-33 | 64 | F | MTC | Neck, bone doubtful | 11 | Su, RIT | 40 | 1.8 | St (12 mo+) | St (12 mo+) |
| 03-34 | 49 | M | MTC | Chest, bone | 352 | Su | 40 | 1.8 | Progression | Progression |
| 01-35 | 62 | M | Rectum adenocarcinoma | Lung, bone, pelvis | 25 | Su, C, R | 40 | 1.3† | Progression | Progression |
| 01-36 | 48 | F | Colon adenocarcinoma | Liver, abdomen | 360 | Su, C | 40 | 2.9 | St (6 mo) | St (3 mo) |
| 03-37 | 51 | M | MTC | Neck, chest, bone | ND | Su | 40 | 1.8 | ND | ND |
| 01-38 | 55 | F | Rectum adenocarcinoma | Lung, liver | 8 | Su, C, R | 40 | 2.9 | Progression | Progression |